Results 211 to 220 of about 63,819 (300)
Allergenicity of α‐Gal‐Containing Products
Allergy, EarlyView.
Frederik Bloch Mangaard +4 more
wiley +1 more source
The preoperative Multi‐Domain Risk Stratification model effectively stratified operative risk in older adults undergoing cholecystectomy for acute cholecystitis, predicting prolonged hospital stay, medical complications, and Medical Emergency Team calls, supporting its role in comprehensive preoperative risk assessment and perioperative decision‐making.
Kate Wylde +6 more
wiley +1 more source
Omalizumab treatment for chronic spontaneous urticaria coinciding with marked improvement of vitiligo: a case report. [PDF]
Lin S, Zhou P, Huang S, Li K, Zhang L.
europepmc +1 more source
ABSTRACT Aim To compare safety and clinical outcomes of two different oral immunotherapy (OIT) maintenance doses (150 mg vs. 300 mg) of peanut protein in children with peanut allergy. Methods This prospective study enrolled 44 children aged 4–17 years with confirmed peanut allergy.
Klementyna Łyżwa +4 more
wiley +1 more source
Evidence-Based Clinical Recommendations on the Appropriateness of Prescriptions and Diagnostic Tests in Paediatric Allergology: Focus on IgE-Mediated and Non-IgE Mediated Food Allergy, Eosinophilic Gastrointestinal Disease, Urticaria, Angioedema and Atopic Dermatitis. [PDF]
Fainardi V +26 more
europepmc +1 more source
Diagnostic performance of recombinant peanut allergens for anaphylaxis risk in children. (A) Study population and clinical group. (B) Component‐specific IgE cut‐offs and associated odds ratios. (C) Forest plot of odds ratios for anaphylaxis. (D) Clinical interpretation of component‐specific IgE cut‐offs. ABSTRACT Aim Component‐resolved diagnostics (CRD)
Lisa Gazzolari +10 more
wiley +1 more source
β-blocker Therapy in Cholinergic Urticaria, Adrenergic Urticaria and the Aquagenic Continuum Beta-Blocker Therapy in Chronic Inducible Urticaria. [PDF]
Hutten EM, Pleijhuis RG.
europepmc +1 more source

